Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Subjects:

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Excluded skewed studies. by Solima Sabeel (9545738)

Subjects:

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Summary of non-randomized studies. by Solima Sabeel (9545738)

Subjects:

Summary table showing analysis of randomized controlled trials stratified based on age groups. by Solima Sabeel (9545738)

Subjects:

The difference of BMD between 2019 and 2022 classify by grop of urinary camium levels measured in 2019. by Aroon La-up (14095691)

Subjects:

Prevalence of osteoporosis classified by sex, and urinary cadmium level compare between 2019 and 2022. by Aroon La-up (14095691)

Subjects:

Stratified analysis of the association between urinary cadmium and bone mineral density, by sex. by Aroon La-up (14095691)

Subjects:

Association between baseline urinary cadmium and the three-year change in bone mineral density (ΔBMD). by Aroon La-up (14095691)

Subjects:

Characteristics of the study participants for continuous variables. by Aroon La-up (14095691)

Subjects:

Prediction for the ecological functional composition of the bacterial community from Functional Annotation of Procaryotic Taxa (FAPROTAX) (A) and relationship between fertilization... by Qian Wang (32718)

Characteristics of Study Participants. by Hyelim Lee (11286822)

Subjects:

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. by Huashen Guan (20454677)

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Participant characteristics, overall and for each transition, of primary analytic sample (activity data for all 14 days of the respective transition period). by Shelby L. Sturrock (10751675)

Subjects: